Skip to main content
. 2019 Jul 2;10(4):e00758-19. doi: 10.1128/mBio.00758-19

TABLE 1.

ZIKV-immune plasma samples included in this studya

Sample
ID
Subject
age
(yrs)
Sex Place of
exposure
Collection
time (days)b
Status Diagnostic tests
and results
Hu0002 28 M Miami, FL Not applicable Healthy Negative for ZIKV, DENV1–DENV4, and CHIKV by PCR and ELISA
Hu0007 53 M Colombia 30 Symptomatic Positive for ZIKV by PCR and ELISA, negative for DENV1–DENV4
by ELISA
Hu0015c 32 F Miami
(Wynwood), FL
5, 7, 15, 21, 28,
48, 56, 70, 91,
116, 148, 249
Symptomatic Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA
Hu0020 32 F Miami (Miami
Beach), FL
180 Symptomatic Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4
by ELISA
Hu0046 57 F Cuba 7, 15, 24, 59 Symptomatic Positive for ZIKV by ELISA, negative for DENV1–DENV4 and CHIKV
by PCR
Hu0049 31 F Miami, FL 247 Asymptomatic Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4
by ELISA
HuK021 36 F Miami, FL 540 Asymptomatic Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4
by ELISA
HuK156 20 Fd Miami, FL 90 Asymptomatic Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4
by ELISA
UTMB3 26 F Honduras 8 Symptomatic Positive for ZIKV by ELISA
UTMB4 26 F Caribbean Islands 18 Symptomatic Positive for ZIKV by ELISA
UTMB7 15 F Colombia 129 Symptomatic Positive for ZIKV, negative for DENV1–DENV4 by PRNT
UTMB8 28 F Colombia 113 Symptomatic Positive for ZIKV, negative for DENV1–DENV4 by PRNT
UTMB134 60 F Colombia 23 Symptomatic Positive for ZIKV by PCR, negative for DENV1–DENV4 and CHIKV
by PCR
BSRI39 43 F Mexico 28, 41, 91, 180,
285
Asymptomatic Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA
BSRI40 26 M NA 25, 38, 89, 180,
297
Symptomatic Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA
BSRI45 28 F Puerto Rico 16, 87 Asymptomatic Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA
a

ID, identifier; F, female; M, male; CHIKV, chikungunya virus; NA, not available.

b

Plasma collection times indicate number of days after the onset of symptoms for symptomatic individuals and post-index donation, the number of days after the first collection day, for asymptomatic individuals.

c

Plasma samples from this individual were previously studied for ZIKV-induced immunity (Ricciardi et al. [29]). Gray-shaded data represent samples derived from asymptomatic volunteers.

d

Individual was pregnant.